Coyote Bioscience Co., Ltd. of Beijing at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Coyote Bioscience Co., Ltd.

Building 15, Zone 1, No. 08 Shengmingyua Changping District, 102206 Beijing
China
Telephone +86 10 64844237
Fax +86 10 64844237-8000
sales@coyotebio.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Huqiu Imaging (Suzhou) Co., Ltd.

Hall map

MEDICA 2021 hall map (Hall 9): stand C61

Fairground map

MEDICA 2021 fairground map: Hall 9

Contact

Natasha Guo

Beijing

Phone
0086 10 64844237

Email
natasha.guo@coyotebio.com

Jeremy Kou

Phone
0086 10 64844237

Email
jeremy@coyotebio.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Our products

Product category: Polymerase chain reaction (PCR)

FlashDetect™ Flash 20 Nucleic Acid Fast Detection System

Features:
• Easy Extraction-free Nucleic Acid
• Fast sample-to-result in 30 mins
• Flexible Random access
• Portable: small and calibration free

Applications:
• Reference lab
• Clinical lab
• Medical clinics
• CDC
• Point-of-care
• Airports
• Quarantine facilities
• Checkpoints
• Mobile labs

More Less

About us

Company portrait

Coyote Bioscience Co., Ltd. (“Coyote”) is a Chinese innovative high-tech company that has been engaged in molecular diagnostics for 10 years, and it especially excels at the fast nucleic acid detection technology for pathogenic microorganisms. Coyote’s core technologies with independent intellectual property rights enable the company to participate in joint development in such interdisciplinary fields as related to instruments, reagents, system platforms, artificial intelligence and big data.

Coyote was founded in 2009, with its headquarters and R&D center in Beijing and an 8,000 square meter GMP production base in Yixing, Jiangsu Province. As a national high-tech enterprise and an experts’ base, the company has been awarded such honors as “China’s Top 50 Most Valuable Enterprises for Investment”, “China’s Most Promising Enterprise”, and “Advanced Collective” for combating the COVID-19 pandemic by the Ministry of Industry and Information Technology in 2020.

Coyote has applied for 83 domestic and international patents, mainly including 22 international PCT patents, 13 domestically authorized patents, 2 US patents and 1 Australian patent. It has participated in the Torch Program of the Ministry of Science and Technology and national major programs for infectious diseases. The corporate vision, “molecular diagnostics for everyone”, which has served as the source of Coyote’s technological innovation in the past 10 years, is also its historical mission in the context of the normalized pandemic influence.

Company data

Sales volume 100-199 Mio US $
Export content max. 50%
Number of employees 500-999
Foundation 2009
Area of business
  • Imaging and diagnostics / medical equipment and devices
  • Laboratory equipment
  • Diagnostic tests